Aqueous suspension for nasal administration of loteprednol
US6368616B1 · kind B1 · utility
21Cited by
1References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 13, 1999 |
| Grant date | Apr 9, 2002 |
| Priority date | — |
| Expiry date | Jul 13, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An aqueous suspension for nasal administration which contains loteprednol etabonate and microcrystalline cellulose carmellose sodium. This aqueous suspension can be administered to nasal mucosa to treat inflammation or allergy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.